Ogivri (trastuzumab)

pCPA File Number: 21129

Negotiation Status:

Concluded with an LOI

Indication(s):

Early breast cancer, Metastatic breast cancer, Metastatic gastric cancer

Sponsor/Manufacturer:

BGP Pharma ULC

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2019-05-30

Negotiation Process Concluded:

2019-10-03